Get started
Author

Kazumasa Hasegawa

Novel Potent Orally Active Selective VEGFR-2 Tyrosine Kinase Inhibitors: Synthesis, Structure−Activity Relationships, and Antitumor Activities of N-Phenyl-N‘-{4-(4-quinolyloxy)phenyl}ureas
2005 · Kazuo Kubo, Toshiyuki Shimizu, et al. · Journal of Medicinal Chemistry · 153
Endosialin Protein Expression and Therapeutic Target Potential in Human Solid Tumors: Sarcoma versus Carcinoma
2008 · Cecile Rouleau, Maritza Curiel, et al. · Clinical Cancer Research · 113
PDF
Complement Activation Plays a Key Role in Antibody-Induced Infusion Toxicity in Monkeys and Rats
2008 · Tomonori Tawara, Kazumasa Hasegawa, et al. · The Journal of Immunology · 59
Preparation, characterization and taste-masking properties of polyvinylacetal diethylaminoacetate microspheres containing trimebutine
2002 · Yoshimi Hashimoto, Masami Tanaka, et al. · Journal of Pharmacy and Pharmacology · 56
Establishment of a novel monoclonal antibody against LGR5
2010 · Yuka Sasaki, Hiromichi Kosaka, et al. · Biochemical and Biophysical Research Communications · 23
Simplifying the Chemical Structure of Cationic Lipids for siRNA-Lipid Nanoparticles
2019 · Takeshi Kuboyama, Kaori Yagi, et al. · ACS Medicinal Chemistry Letters · 19
A Pharmacologic Study on the Mechanism of Action of Kakkon-to : Body Temperature Elevation and Phagocytic Activation of Macrophages in Dogs
2004 · Kenichi Muraoka, Satoshi Yoshida, et al. · The Journal of Alternative and Complementary Medicine · 14
Synthesis of (.+-.)-8-Deisopropyladunctin B
2012 · Sayo Nomura, Kenji Arimitsu, et al. · Chemical and Pharmaceutical Bulletin · 8
PDF
Fully human antibody exhibits pan‐human leukocyte antigen‐DR recognition and high in vitro/vivo efficacy against human leukocyte antigen‐DR‐positive lymphomas
2007 · Tomonori Tawara, Kazumasa Hasegawa, et al. · Cancer Science · 7
PDF
The novel CA IX inhibition antibody chKM4927 shows anti-tumor efficacy in vivo.
2015 · Ayami Yamaguchi, Katsuaki Usami, et al. · PubMed · 2
Supplementary Data from Endosialin Protein Expression and Therapeutic Target Potential in Human Solid Tumors: Sarcoma versus Carcinoma
2023 · Cecile Rouleau, Maritza Curiel, et al.
Data from Endosialin Protein Expression and Therapeutic Target Potential in Human Solid Tumors: Sarcoma versus Carcinoma
2023 · Cecile Rouleau, Maritza Curiel, et al.
Data from Endosialin Protein Expression and Therapeutic Target Potential in Human Solid Tumors: Sarcoma versus Carcinoma
2023 · Cecile Rouleau, Maritza Curiel, et al.
Supplementary Data from Endosialin Protein Expression and Therapeutic Target Potential in Human Solid Tumors: Sarcoma versus Carcinoma
2023 · Cecile Rouleau, Maritza Curiel, et al.
PDF
Data from KRN951, a Highly Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Has Antitumor Activities and Affects Functional Vascular Properties
2023 · Kazuhide Nakamura, Eri Taguchi, et al.
Supplementary Table 1 from KRN951, a Highly Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Has Antitumor Activities and Affects Functional Vascular Properties
2023 · Kazuhide Nakamura, Eri Taguchi, et al.
Data from KRN951, a Highly Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Has Antitumor Activities and Affects Functional Vascular Properties
2023 · Kazuhide Nakamura, Eri Taguchi, et al.
Blood Pressure Elevation in Patients Undergoing FOLFOX / FOLFIRI Therapy
2011 · Toyoji Ohtani, Eiji Hata, et al. · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
PDF
Pharmacological study on the mechanism of action of the "Kakkon-to" preparation : Body tmeperature rise and phagocytic activation of macrophages in dogs
2003 · Kenichi Muraoka, Satoshi Yoshida, et al.
Works count: 19
Citation count: 454
H-index: 8
I10-index: 7
Year
Topic
Type